Wei Zhang
@weizhang-liver.bsky.social
Hepatologist interested in alcohol associated liver disease at Massachusetts General Hospital and Harvard medical school
Reposted by Wei Zhang
Reposted by Wei Zhang
Read this
A review of reported adverse events for medications to treat alcohol use disorder
we must reduce alcohol use in people with liver disease
And to increase uptake of useful tools …
we need stop repeating that naltrexone is hepatotoxic
doi.org/10.1016/j.cg...
A review of reported adverse events for medications to treat alcohol use disorder
we must reduce alcohol use in people with liver disease
And to increase uptake of useful tools …
we need stop repeating that naltrexone is hepatotoxic
doi.org/10.1016/j.cg...
January 22, 2025 at 1:36 AM
Read this
A review of reported adverse events for medications to treat alcohol use disorder
we must reduce alcohol use in people with liver disease
And to increase uptake of useful tools …
we need stop repeating that naltrexone is hepatotoxic
doi.org/10.1016/j.cg...
A review of reported adverse events for medications to treat alcohol use disorder
we must reduce alcohol use in people with liver disease
And to increase uptake of useful tools …
we need stop repeating that naltrexone is hepatotoxic
doi.org/10.1016/j.cg...